NTHINEONC TECHNOLOGIES HOLDINGS, INC.
- GlobeNewswire
NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
CALABASAS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for ...
- GlobeNewswire
Four Elevated Short Interest Stocks as Oil Retreats and Midterm Elections Approach
DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) -- (247MarketNews.com) — Lifetime Brands (NASDAQ:LCUT), NeOnc Technologies Holdings (NASDAQ:NTHI), The Children's Place (NASDAQ:PLCE), and Cable One (NYSE:CABO) offer four ...
- GlobeNewswire
NeOnc Is Putting Two Brain Cancer Programs on the Global Stage
DENVER, Nov. 02, 2026 (GLOBE NEWSWIRE) -- (247MarketNews.com) — In a market where the latest investment trends often dominate attention, NeOnc Technologies Holdings (NASDAQ:NTHI) is developing a story that could ...
- GlobeNewswire
NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology
CALABASAS, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for ...
- GlobeNewswire
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
DENVER, Oct. 30, 2026 (GLOBE NEWSWIRE) -- (247MarketNews.com) — In a market where the latest whizbang trends often dominate investor attention, NeOnc Technologies Holdings (NASDAQ:NTHI) is pursuing something ...
- GlobeNewswire
2027 Could Finally Be the Year Cancer Is on the Ropes!
DENVER, Oct. 29, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) As 2027 approaches, developments across the United States, Europe and Asia are giving patients, researchers and healthcare markets new reasons to pay ...
- GlobeNewswire
Defining Moments in the Race for Biotech Breakthroughs
DENVER, Oct. 26, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — These biotechnology companies are advancing important developments. NeOnc Technologies Holdings (NASDAQ:NTHI) is outlining plans for a major ...
- GlobeNewswire
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
DENVER, Oct. 26, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ:NTHI) is setting its sights on a substantially larger international clinical effort, outlining plans for a trial ...
- GlobeNewswire
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue
DENVER, Oct. 23, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ:NTHI) cleared several key resistance levels, on strong trading volume, delivering a potentially important technical ...
- GlobeNewswire
Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly’s Next Growth Chapter
DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — Healthcare stocks are presenting investors with a mix of pharmaceutical growth stories and catalysts. Pfizer (NYSE:PFE) is drawing renewed attention to ...
- GlobeNewswire
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ:NTHI) is taking its brain cancer research story to a national television audience at a moment when several ...
- GlobeNewswire
NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy
CALABASAS, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for ...
- GlobeNewswire
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Brain cancer remains one of the hardest cancers to treat, and researchers are under pressure to find therapies that do more than slow the disease for a short time. For ...
- GlobeNewswire
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
DENVER, Oct. 21, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — "I wish someone had told me about that company." That is a familiar reaction when a stock attracts attention after investors have spent months ...
- GlobeNewswire
NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration
Proposed collaboration covers scientific exchange, specialist training and real-world evidence, alongside assessment of clinical trial opportunities and a potential regional presence for NeOnc in Abu Dhabi Two children ...
- GlobeNewswire
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season
DENVER, Oct. 20, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- At an ugly-sweater party, the one with the most flair gets everyone talking. On Wall Street, attention can shift just as quickly when a battered chart ...
- GlobeNewswire
NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone
DENVER, Oct. 16, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ:NTHI) delivered a deeply human clinical update that brings its investigational brain-cancer technology, expanding ...
- GlobeNewswire
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
CALABASAS, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for ...
- GlobeNewswire
From Shaq to Musk: The Power Appointment Effect
DENVER, Oct. 15, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – The right appointment can do more than fill a board seat. It can change a company’s public profile, open doors to new partnerships, reshape its ...
- GlobeNewswire
UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances
DENVER, Oct. 15, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – NeOnc Technologies Holdings (NASDAQ:NTHI) made a powerful leadership move at a pivotal moment in its brain-cancer drug development strategy. The ...
- GlobeNewswire
NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026
CALABASAS, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies ...
- GlobeNewswire
NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development
DENVER, Oct. 14, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ:NTHI) is strengthening its boardroom, while its clinical-development progress seeks to advance treatments for some ...
- GlobeNewswire
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors
CALABASAS, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for ...
- GlobeNewswire
2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope
DENVER, Oct. 07, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) -- For patients facing cancer, progress ultimately comes down to a deeply personal question: Can treatment give them more time? A series of ...
- GlobeNewswire
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
DENVER, Oct. 07, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com)-- For patients facing cancer, progress ultimately comes down to a deeply personal question: Can treatment give them more time? A series of ...